InvestorsHub Logo
Followers 24
Posts 2137
Boards Moderated 0
Alias Born 01/24/2019

Re: Ryoko post# 705

Saturday, 04/13/2019 5:45:50 PM

Saturday, April 13, 2019 5:45:50 PM

Post# of 1245
There are 3,000,000 PAD cases in the US every year. Avinger hopes to and will achieve 20% market penetration with per treatment sales at $3,000. That results in $1.8B in revenue a year. So for under $1/share and under a $35M maket cap.

AVGR commercialized in Australia in Dec. 2018.

https://finance.yahoo.com/news/avinger-announces-commercial-launch-australia-130000421.html

They will be announcing something soon here on this imo.

ER expected in May.

Would not be surprised to see them get bought out now.

Don't forget this stock was over $900 Jan. 2016

imo
glta
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVGR News